Phlow Corp. Appoints General Gustave F. Perna to the Phlow Business Advisory Board
May 06 2024 - 9:29AM
Phlow Corp., a U.S.-based certified B Corporation leveraging
advanced development and manufacturing processes to re-imagine the
domestic production of pharmaceutical products critical to U.S.
healthcare, announced today that it has appointed General Gustave
F. Perna to the Phlow Business Advisory Board (PBAB). As America's
modern medicine manufacturer, Phlow works closely with its business
advisory board, a team made up of internationally recognized
leaders and visionaries, to drive a strategy focused on stabilizing
our supply chain and ending chronic shortages of essential
medicines and medical countermeasures for Americans.
"We are thrilled to have General Perna serve on our advisory
board as we work together to secure America's pharmaceutical
sovereignty, including reducing the overreliance on foreign supply
chains for critical essential medicines and medical countermeasures
our warfighters and military hospitals depend upon to sustain life
and operate effectively," said Eric Edwards, M.D., Ph.D.,
co-founder and CEO of Phlow.
General Perna honorably served in the United States Army for
over 40 years, retiring as a Four-Star General in 2021, having last
served as chief operating officer for Operation Warp Speed, where
he led the United States national effort to research, develop,
produce, distribute, and administer vaccines and therapeutics to
combat COVID-19. Additionally, General Perna served as the
Commander of the U.S. Army Materiel Command. As the Department of
Defense's second largest organization, with units comprised of over
190,000 soldiers, General Perna provided oversight for the Army's
readiness, training, execution, munitions supply chain, and
contracting operations, as well as commanded the Joint Munitions
Command, leading the efficient and effective procurement of
essential items for the entire Department of Defense.
"As someone who has seen first-hand the challenges that COVID-19
exposed in our Nation's pharmaceutical supply chain, I am thrilled
to join Phlow's Business Advisory Board. Together, we can work
towards creating high-quality medicines domestically and building a
resilient supply chain in the United States. This will not only
strengthen our national defense but will also make a positive
impact on our country's healthcare system," said General Gustave F.
Perna.
General Perna has proven strengths in executive leadership,
strategy, supply chain, logistics, and talent development in
global, rapidly paced, and forward-thinking organizations. He
utilized Defense Production Act authority on over 19 contracts to
energize the biopharmaceutical industrial base through analysis of
production, labor, and supply chain management. His relentless
dedication to the cause helped deliver over 400M doses of vaccines
to the American people in thirteen months and secure production for
over 1.6B doses of vaccines and therapeutics. He also serves as a
director on the boards of Allison Transmission, MD Helicopters, 280
Earth, Paradigm Health, and Corvias. Within these roles, he sits on
audit, compliance, and nominating and corporate governance
committees."Transforming the industry requires an unflinching
commitment to pushing beyond the way medicines have been made and
distributed for decades. General Perna is the type of resolute
leader that will help Phlow move beyond the status quo and ensure
our essential medicine supply chain is resilient, secure, and
stable for all Americans," said Edwards.
About PhlowPhlow is a U.S.-based, Certified B
Corporation™ leveraging advanced manufacturing processes to
re-imagine the domestic production of key starting materials (KSM),
active pharmaceutical ingredients (API), and finished drug products
that are critical to U.S. healthcare. Focused on impact, Phlow
partners with children's hospitals, private industry, and the U.S.
government to increase access to affordable, high-quality,
life-changing medicines through advanced manufacturing processes
that are fully integrated, comprehensive, and better for the
environment. Utilizing its advanced R&D labs and best-in-class,
automated API cGMP facilities ranging from kilo to metric ton
scales, Phlow provides customized contract development and
manufacturing services for small molecule APIs to pharmaceutical
and biotech companies. Phlow measures its success by driving down
costs and waste, improving quality and yield, and offering a more
environmentally friendly approach to manufacturing medicines that
lead to healthy and resilient communities. For more, visit
www.phlow-usa.com.
Leslie Strickler
Phlow Corp.
leslies@etrecommunications.com
Paul Spicer
Phlow Corp.
pspicer@phlow-usa.com